Eileen Tsai Chambers
Overview
Explore the profile of Eileen Tsai Chambers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pizzo H, Nguyen J, Schwartz G, Wesseling-Perry K, Ettenger R, Chambers E, et al.
Pediatr Nephrol
. 2024 Mar;
39(7):2177-2186.
PMID: 38427073
Background: An accurate, rapid estimate of glomerular filtration rate (GFR) in kidney transplant patients affords early detection of transplant deterioration and timely intervention. This study compared the performance of serum...
2.
Rheault M, Amaral S, Bock M, Chambers E, Chavers B, Ters M, et al.
Front Nephrol
. 2023 Sep;
3:1181076.
PMID: 37675355
Background: Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage kidney disease requiring kidney transplantation and can recur in the allograft in 30-80% of recipients resulting in reduced graft...
3.
Pearl M, Weng P, Chen L, Dokras A, Pizzo H, Garrison J, et al.
Clin Transplant
. 2022 Jun;
36(8):e14734.
PMID: 35657013
Background: Treatment options for antibody-mediated rejection (AMR) are limited. Recent studies have shown that inhibition of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling can reduce inflammation and slow AMR progression. Methods: We...
4.
Pearl M, Chen L, ElChaki R, Elashoff D, Gjertson D, Rossetti M, et al.
Kidney Int Rep
. 2020 Nov;
5(11):1925-1936.
PMID: 33163713
Introduction: Autoantibody to angiotensin II type 1 receptor (AT1R-Ab) has been recognized as a non-human leukocyte antigen (HLA) antibody relevant in transplantation. Endothelin type A receptor antibody (ETAR-Ab) has been...
5.
6.
Chambers E, Gbadegesin R
Kidney Int
. 2019 Sep;
96(4):818-820.
PMID: 31543150
Although the pathogenesis of steroid-sensitive nephrotic syndrome (SSNS) remains elusive, multiple epidemiologic, clinical, and experimental studies converge on the common theme of immune dysregulation. Initially, T-cell adaptive immunity was solely...
7.
Friend B, Schneider K, Garrington T, Truscott L, Martinez-Agosto J, Venick R, et al.
Mol Genet Genomic Med
. 2019 Jun;
7(7):e00725.
PMID: 31197971
Background: Polycystic kidney disease (PKD) is an inherited condition characterized by progressive development of end-stage renal disease, hypertension, hepatic fibrosis, and cysts in the kidney, liver, pancreas, spleen, thyroid, and...
8.
Pearl M, Grotts J, Rossetti M, Zhang Q, Gjertson D, Weng P, et al.
Kidney Int Rep
. 2019 Apr;
4(4):541-550.
PMID: 30997435
Introduction: Angiotensin II type 1 receptor antibody (AT1R-Ab), is a non-human leukocyte antigen (HLA) antibody implicated in poor renal allograft outcomes, although its actions may be mediated through a different...
9.
Pearl M, Zhang Q, Palma Diaz M, Grotts J, Rossetti M, Elashoff D, et al.
Kidney Int
. 2017 Sep;
93(1):260-269.
PMID: 28927645
Angiotensin II type 1 receptor (AT1R) antibody has been linked to poor allograft outcomes in adult kidney transplantation. However, its clinical consequences in children are unknown. To study this, we...
10.
Weng P, Alejos J, Halnon N, Zhang Q, Reed E, Chambers E
Pediatr Transplant
. 2017 Jul;
21(7).
PMID: 28727227
Pediatric sHKTx has become an effective therapy for patients with combined cardiac and renal failure. Often, these patients develop human leukocyte antigen antibodies from their previous allografts and are therefore...